HomeCompareCYBQF vs ORCC

CYBQF vs ORCC: Dividend Comparison 2026

CYBQF yields 116.28% · ORCC yields 9.79%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CYBQF wins by $7.40M in total portfolio value
10 years
CYBQF
CYBQF
● Live price
116.28%
Share price
$1.72
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$7.42M
Annual income
$2,756,053.49
Full CYBQF calculator →
ORCC
ORCC
● Live price
9.79%
Share price
$13.48
Annual div
$1.32
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.4K
Annual income
$1.04
Full ORCC calculator →

Portfolio growth — CYBQF vs ORCC

📍 CYBQF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCYBQFORCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CYBQF + ORCC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CYBQF pays
ORCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CYBQF
Annual income on $10K today (after 15% tax)
$9,883.72/yr
After 10yr DRIP, annual income (after tax)
$2,342,645.47/yr
ORCC
Annual income on $10K today (after 15% tax)
$832.34/yr
After 10yr DRIP, annual income (after tax)
$0.88/yr
At 15% tax rate, CYBQF beats the other by $2,342,644.58/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CYBQF + ORCC for your $10,000?

CYBQF: 50%ORCC: 50%
100% ORCC50/50100% CYBQF
Portfolio after 10yr
$3.72M
Annual income
$1,378,027.26/yr
Blended yield
37.04%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

CYBQF
No analyst data
Altman Z
2.8
Piotroski
2/9
ORCC
Analyst Ratings
9
Buy
4
Hold
1
Sell
Consensus: Buy
Price Target
$16.00
+18.7% upside vs current
Range: $16.00 — $16.00
Altman Z
0.5
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CYBQF buys
0
ORCC buys
0
No recent congressional trades found for CYBQF or ORCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCYBQFORCC
Forward yield116.28%9.79%
Annual dividend / share$2.00$1.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%-50%
Portfolio after 10y$7.42M$21.4K
Annual income after 10y$2,756,053.49$1.04
Total dividends collected$6.72M$1.0K
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: CYBQF vs ORCC ($10,000, DRIP)

YearCYBQF PortfolioCYBQF Income/yrORCC PortfolioORCC Income/yrGap
1← crossover$22,328$11,627.91$11,190$489.61+$11.1KCYBQF
2$48,155$24,264.19$12,229$256.01+$35.9KCYBQF
3$100,433$48,907.54$13,216$130.74+$87.2KCYBQF
4$202,794$95,329.78$14,207$66.02+$188.6KCYBQF
5$396,885$179,895.62$15,234$33.17+$381.7KCYBQF
6$753,705$329,038.76$16,317$16.62+$737.4KCYBQF
7$1,390,448$583,983.43$17,468$8.32+$1.37MCYBQF
8$2,494,642$1,006,861.95$18,695$4.16+$2.48MCYBQF
9$4,357,527$1,688,260.58$20,006$2.08+$4.34MCYBQF
10$7,418,607$2,756,053.49$21,407$1.04+$7.40MCYBQF

CYBQF vs ORCC: Complete Analysis 2026

CYBQFStock

CYBERDYNE Inc. researches, develops, produces, sell, leases, and maintains equipment and systems for medical and warfare in Japan. The company offers Hybrid Assistive Limb (HAL) for medical use in lower limb and single joint type; non-medical HAL for lower limb, single joint type, and lumbar type; HAL peripherals; cleaning robots; transportation robots for various transportation tasks in factories, offices, and other indoor environments; and Acoustic X, a high speed light pulse LED array light source that enables real time photoacoustic imaging. It also provides Cybernics Treatment, a treatment that uses HAL to enhance/regenerate the function of the wearer for spinal cord injury, stroke, neuromuscular diseases, etc.; HAL FIT for enhancement of brain-nerve-musculoskeltal system; MTX Neuro HAL Plus to enhance the performance of the athletes' brain-nerve functions; and Neuro HALFIT for enhancement of physical functions. In addition, the company is involved in the provision of rescue supports in disaster sites, and heavy labor supports for factories and plants; and entertainment business. The company was incorporated in 2004 and is headquartered in Tsukuba, Japan.

Full CYBQF Calculator →

ORCCBDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →
📬

Get this CYBQF vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CYBQF vs SCHDCYBQF vs JEPICYBQF vs OCYBQF vs KOCYBQF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.